JP6566612B2 - 免疫体質又は免疫応答型を判定するためのバイオマーカー及び免疫応答型制御剤 - Google Patents

免疫体質又は免疫応答型を判定するためのバイオマーカー及び免疫応答型制御剤 Download PDF

Info

Publication number
JP6566612B2
JP6566612B2 JP2014133367A JP2014133367A JP6566612B2 JP 6566612 B2 JP6566612 B2 JP 6566612B2 JP 2014133367 A JP2014133367 A JP 2014133367A JP 2014133367 A JP2014133367 A JP 2014133367A JP 6566612 B2 JP6566612 B2 JP 6566612B2
Authority
JP
Japan
Prior art keywords
mir
immune response
expression level
hsa
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2014133367A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016010346A5 (enExample
JP2016010346A (ja
Inventor
秀光 北村
秀光 北村
紹信 武冨
紹信 武冨
陽介 大野
陽介 大野
淳矢 大竹
淳矢 大竹
聖 寺田
聖 寺田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hokkaido University
Original Assignee
Hokkaido University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hokkaido University filed Critical Hokkaido University
Priority to JP2014133367A priority Critical patent/JP6566612B2/ja
Publication of JP2016010346A publication Critical patent/JP2016010346A/ja
Publication of JP2016010346A5 publication Critical patent/JP2016010346A5/ja
Application granted granted Critical
Publication of JP6566612B2 publication Critical patent/JP6566612B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2014133367A 2014-06-27 2014-06-27 免疫体質又は免疫応答型を判定するためのバイオマーカー及び免疫応答型制御剤 Active JP6566612B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014133367A JP6566612B2 (ja) 2014-06-27 2014-06-27 免疫体質又は免疫応答型を判定するためのバイオマーカー及び免疫応答型制御剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014133367A JP6566612B2 (ja) 2014-06-27 2014-06-27 免疫体質又は免疫応答型を判定するためのバイオマーカー及び免疫応答型制御剤

Publications (3)

Publication Number Publication Date
JP2016010346A JP2016010346A (ja) 2016-01-21
JP2016010346A5 JP2016010346A5 (enExample) 2018-02-22
JP6566612B2 true JP6566612B2 (ja) 2019-08-28

Family

ID=55227534

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014133367A Active JP6566612B2 (ja) 2014-06-27 2014-06-27 免疫体質又は免疫応答型を判定するためのバイオマーカー及び免疫応答型制御剤

Country Status (1)

Country Link
JP (1) JP6566612B2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019050772A (ja) * 2017-09-15 2019-04-04 国立大学法人 熊本大学 ワクチン接種後副反応を予測する検査方法
US11055844B2 (en) * 2018-02-21 2021-07-06 Case Western Reserve University Predicting response to immunotherapy using computer extracted features of cancer nuclei from hematoxylin and eosin (HandE) stained images of non-small cell lung cancer (NSCLC)
JP7835418B1 (ja) * 2025-01-14 2026-03-25 国立大学法人神戸大学 がんワクチンの効果予測

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010294197C9 (en) * 2009-09-10 2018-09-13 Velin-Pharma A/S Method for the preparation of micro-RNA and its therapeutic application
AU2012223237A1 (en) * 2011-03-02 2013-05-02 Groove Biopharma Corporation Enhanced biodistribution of oligomers
JP6385732B2 (ja) * 2014-06-27 2018-09-05 国立大学法人北海道大学 免疫応答制御剤

Also Published As

Publication number Publication date
JP2016010346A (ja) 2016-01-21

Similar Documents

Publication Publication Date Title
Jiao et al. Differences in tumor microenvironment dictate T helper lineage polarization and response to immune checkpoint therapy
JP7428397B2 (ja) 免疫調節性ｍ２単球を選択的に低減することによってがんを治療し、治療的免疫を増強するための方法および組成物
Hennessy et al. Targeting Toll-like receptors: emerging therapeutics?
JP7731656B2 (ja) Ｒｎａ癌ワクチン
US11186825B2 (en) Compositions and methods for evaluating and modulating immune responses by detecting and targeting POU2AF1
US11180730B2 (en) Compositions and methods for evaluating and modulating immune responses by detecting and targeting GATA3
Borgers et al. Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial
US12241053B2 (en) Modulation of novel immune checkpoint targets
US20190100801A1 (en) Compositions and methods for evaluating and modulating immune responses by use of immune cell gene signatures
Meraviglia-Crivelli et al. IL-6/STAT3 signaling in tumor cells restricts the expression of frameshift-derived neoantigens by SMG1 induction
Platten et al. Microenvironmental clues for glioma immunotherapy
US20230295736A1 (en) Compositions and methods comprising digital signatures to predict response and resistance to targeted therapy and immunotherapy
KR20190020299A (ko) 면역 조정 폴리펩타이드를 암호화하는 mRNA의 조합물 및 이의 용도
EP3516043A1 (en) T cell expansion method
KR20140074997A (ko) 신경병성 질환에서 마이크로rna
Tonti et al. Bisphosphonates target B cells to enhance humoral immune responses
JP5013870B2 (ja) 細胞および／または組織および／または疾患フェーズ特異的な薬剤の製造方法
US20160326525A1 (en) Use of mirna-214 inhibitor in inhibiting regulatory cells
Ambrożej et al. “Liquid biopsy”-extracellular vesicles as potential novel players towards precision medicine in asthma
JP2016010346A (ja) 免疫体質又は免疫応答型を判定するためのバイオマーカー及び免疫応答型制御剤
Rawat et al. The CD200-CD200R cross-talk helps Leishmania donovani to down regulate macrophage and CD4+ CD44+ T cells effector functions in an NFκB independent manner
JP6385732B2 (ja) 免疫応答制御剤
EP3898948A1 (en) Mirna for use in therapy
EP3402508A1 (en) Methods and compositions for modulating thymic function
KR20230035691A (ko) 면역 요법제에 대한 용량 결정

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20140630

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170627

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20170627

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20170704

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180115

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180424

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20180425

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180618

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180816

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190115

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190318

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190702

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190730

R150 Certificate of patent or registration of utility model

Ref document number: 6566612

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250